Page last updated: 2024-11-08

pilocarpine and Branch Vein Occlusion

pilocarpine has been researched along with Branch Vein Occlusion in 2 studies

Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.

Research Excerpts

ExcerptRelevanceReference
"Fifty-two per cent of central retinal vein occlusion and 71% of branch retinal vein occlusion eyes that released pigment showed a rise in intraocular pressure."1.28Mechanisms leading to an acute rise in intraocular pressure in retinal vein occlusion. ( Ansons, AM; Bryce, I; Clearkin, L, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halikiopoulos, D1
Serle, JB1
Ansons, AM1
Clearkin, L1
Bryce, I1

Other Studies

2 other studies available for pilocarpine and Branch Vein Occlusion

ArticleYear
Angle closure glaucoma secondary to hemiretinal vein occlusion.
    The British journal of ophthalmology, 2001, Volume: 85, Issue:11

    Topics: Glaucoma, Angle-Closure; Humans; Laser Therapy; Male; Middle Aged; Mydriatics; Pilocarpine; Pupil Di

2001
Mechanisms leading to an acute rise in intraocular pressure in retinal vein occlusion.
    Eye (London, England), 1990, Volume: 4 ( Pt 3)

    Topics: Adult; Aged; Anterior Eye Segment; Diabetes Complications; Diabetes Mellitus; Eye; Female; Glucose T

1990